Cargando…

CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells

Regulatory T cells (Tregs) are critical mediators of immune homeostasis. The co-stimulatory molecule CD27 is a marker of highly suppressive Tregs, although the role of the CD27-CD70 receptor-ligand interaction in Tregs is not clear. Here we show that after prolonged in vitro stimulation, a significa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arroyo Hornero, Rebeca, Georgiadis, Christos, Hua, Peng, Trzupek, Dominik, He, Li-Zhen, Qasim, Waseem, Todd, John A., Ferreira, Ricardo C., Wood, Kathryn J., Issa, Fadi, Hester, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360768/ https://www.ncbi.nlm.nih.gov/pubmed/32665635 http://dx.doi.org/10.1038/s42003-020-1097-8

Ejemplares similares

Homing of Regulatory T Cells to Human Skin Is Important for the Prevention of Alloimmune-Mediated Pathology in an In Vivo Cellular Therapy Model
por: Issa, Fadi, et al.
Publicado: (2012)

CD45RA Distinguishes CD4+CD25+CD127−/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression
por: Arroyo Hornero, Rebeca, et al.
Publicado: (2017)

Transiently Activated Human Regulatory T Cells Upregulate BCL-XL Expression and Acquire a Functional Advantage in vivo
por: Issa, Fadi, et al.
Publicado: (2019)

Regulatory T-cell therapy approaches
por: McCallion, Oliver, et al.
Publicado: (2022)

The Impact of Dietary Components on Regulatory T Cells and Disease
por: Arroyo Hornero, Rebeca, et al.
Publicado: (2020)

Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use
por: Alzhrani, Alaa, et al.
Publicado: (2020)

IL-33 drives the production of mouse regulatory T cells with enhanced in vivo suppressive activity in skin transplantation
por: Kawai, Kento, et al.
Publicado: (2021)

Dissecting the role of CSF2RB expression in human regulatory T cells
por: Côrte-Real, Beatriz F., et al.
Publicado: (2022)

Ex vivo-expanded human CD19(+)TIM-1(+) regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis
por: Shankar, S., et al.
Publicado: (2022)

Dampened Inflammatory Signalling and Myeloid-Derived Suppressor-Like Cell Accumulation Reduces Circulating Monocytic HLA-DR Density and May Associate With Malignancy Risk in Long-Term Renal Transplant Recipients
por: Bottomley, Matthew J., et al.
Publicado: (2022)

Therapeutically expanded human regulatory T-cells are super-suppressive due to HIF1A induced expression of CD73
por: Jarvis, Lorna B., et al.
Publicado: (2021)

Fast and Efficient Genome Editing of Human FOXP3(+) Regulatory T Cells
por: Van Zeebroeck, Lauren, et al.
Publicado: (2021)

Ex Vivo Expanded Human Regulatory T Cells Can Prolong Survival of a Human Islet Allograft in a Humanized Mouse Model
por: Wu, Douglas C., et al.
Publicado: (2013)

In vivo Prevention of Transplant Arteriosclerosis by ex vivo Expanded Human Regulatory T Cells
por: Nadig, Satish N., et al.
Publicado: (2010)

Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients
por: Brook, Matthew Oliver, et al.
Publicado: (2022)

Discovery of CD80 and CD86 as recent activation markers on regulatory T cells by protein-RNA single-cell analysis
por: Trzupek, Dominik, et al.
Publicado: (2020)

Barriers to Treg therapy in Europe: From production to regulation
por: Hennessy, Conor, et al.
Publicado: (2023)

Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection
por: VanDyke, Derek, et al.
Publicado: (2022)

Editorial: Regulatory T Cells
por: Issa, Fadi, et al.
Publicado: (2022)

Translating tolerogenic therapies to the clinic – where do we stand?
por: Issa, Fadi, et al.
Publicado: (2012)

Base-edited CAR T cells for combinational therapy against T cell malignancies
por: Georgiadis, Christos, et al.
Publicado: (2021)

Recent advances in our understanding of the allograft response
por: Hennessy, Conor, et al.
Publicado: (2021)

Expanding the Regulatory Repertoire of GEFs
por: Robinson, Richard
Publicado: (2013)

Humanization of Immunodeficient Animals for the Modeling of Transplantation, Graft Versus Host Disease, and Regenerative Medicine
por: Adigbli, George, et al.
Publicado: (2020)

Immune Monitoring for Advanced Cell Therapy Trials in Transplantation: Which Assays and When?
por: Stark, Helen L., et al.
Publicado: (2021)

The expanding family of regulatory B cells
por: Mauri, Claudia, et al.
Publicado: (2015)

Development of LT-HSC-Reconstituted Non-Irradiated NBSGW Mice for the Study of Human Hematopoiesis In Vivo
por: Adigbli, George, et al.
Publicado: (2021)

Freezing Medium Containing 5% DMSO Enhances the Cell Viability and Recovery Rate After Cryopreservation of Regulatory T Cell Products ex vivo and in vivo
por: Kaiser, Daniel, et al.
Publicado: (2021)

T regulatory cells and the control of alloimmunity: from characterisation to clinical application
por: Wieckiewicz, Joanna, et al.
Publicado: (2010)

Ischemia-Reperfusion Injury Accelerates Human Antibody-Mediated Transplant Vasculopathy
por: Goto, Ryoichi, et al.
Publicado: (2013)

Quantification of CD4(+) T Cell Alloreactivity and Its Control by Regulatory T Cells Using Time‐Lapse Microscopy and Immune Synapse Detection
por: Juvet, S. C., et al.
Publicado: (2016)

Prolonged Survival of Allografts Induced by Mycobacterial Hsp70 Is Dependent on CD4+CD25+ Regulatory T Cells
por: Borges, Thiago J., et al.
Publicado: (2010)

Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients
por: Harden, Paul N., et al.
Publicado: (2021)

Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders
por: Vanhove, Bernard, et al.
Publicado: (2017)

The expanding regulatory network of STING-mediated signaling
por: Surpris, Guy, et al.
Publicado: (2016)

Chimeric antigen receptor‐modified human regulatory T cells that constitutively express IL‐10 maintain their phenotype and are potently suppressive
por: Mohseni, Yasmin R., et al.
Publicado: (2021)

Cytosine Deaminase Base Editing to Restore COL7A1 in Dystrophic Epidermolysis Bullosa Human: Murine Skin Model
por: Naso, Gaetano, et al.
Publicado: (2023)

Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction
por: Gong, Lanqi, et al.
Publicado: (2023)

Single-cell multi-omics analysis reveals IFN-driven alterations in T lymphocytes and natural killer cells in systemic lupus erythematosus
por: Trzupek, Dominik, et al.
Publicado: (2022)

Building better polymerases: Engineering the replication of expanded genetic alphabets
por: Ouaray, Zahra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g1mkefl6f93f8daoofcbfg7h1p